Smartphones and wearable devices could revolutionise medical care for people with brain disorders
New collaborative research programme will explore potential of wearable devices to help prevent and treat depression, multiple sclerosis and epilepsy
Software AG (Frankfurt TecDAX: SOW) announced a major new research programme supported by the Innovative Medicines Initiative (IMI) launches today, which will develop new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology.